Year archive

Nykode Therapeutics ASA — 2026 filings

All 30 regulatory filings released by Nykode Therapeutics ASA (NYKD) in 2026, sourced directly from the official regulator.

30 Filings

2026 Period

2026 filings (30)

Filing	Released	Lang
Nykode Therapeutics – Invitation to Q1 2026 Financial Results Presentation - Attachment: 260518_Nykode Therapeutics_Q1 2026 Invitation to webcast__.pdf Report Publication Announcement	2026-05-18	English
Nykode Therapeutics – Invitation to Q1 2026 Financial Results Presentation Report Publication Announcement	2026-05-18	English
Nykode Therapeutics ASA - Minutes of Annual General Meeting - Attachment: 260513 - Nykode AGM Minutes.pdf Declaration of Voting Results & Voting Rights Announcements	2026-05-13	Norwegian Bokmål
Nykode Therapeutics ASA - Minutes of Annual General Meeting Report Publication Announcement	2026-05-13	English
Nykode Therapeutics Doses First Patient in Abili-T Phase II Randomized Trial evaluating Abi-suva in HPV16-Positive, PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer Patients - Attachment: Regulatory Filings	2026-05-07	Norwegian
Nykode Therapeutics Doses First Patient in Abili-T Phase II Randomized Trial evaluating Abi-suva in HPV16-Positive, PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer Patients Regulatory Filings	2026-05-07	Norwegian
Nykode Therapeutics Presents AI-Powered Immunotherapy Design Capabilities at BioPharma Drug Discovery Nexus 2026 - Attachment: 260430 - BioPharma Drug Discovery Nexus 2026 (AI)_Final.pdf Regulatory Filings	2026-04-30	English
Nykode Therapeutics Presents AI-Powered Immunotherapy Design Capabilities at BioPharma Drug Discovery Nexus 2026 Regulatory Filings	2026-04-30	English
Nykode Therapeutics ASA - Notice of Annual General Meeting - Attachment: 260421 - NYKD - AGM notice 2026 .pdf Proxy Solicitation & Information Statement	2026-04-21	English
Nykode Therapeutics ASA - Notice of Annual General Meeting AGM Information	2026-04-21	English
Nykode Therapeutics Presents Additional Immunogenicity Data from VB-C-03 Trial at the 2026 American Association for Cancer Research (AACR) Annual Meeting - Attachment: 260420 - AACR press release_FINA Regulatory Filings	2026-04-20	English
Nykode Therapeutics Presents Additional Immunogenicity Data from VB-C-03 Trial at the 2026 American Association for Cancer Research (AACR) Annual Meeting Regulatory Filings	2026-04-20	English
Nykode Therapeutics - Annual Report 2025 - Attachment: nykode-2025-12-31-0-en.zip Regulatory Filings	2026-04-17	Norwegian
Nykode Therapeutics - Annual Report 2025 - Attachment: Nykode Therapeutics ASA - Annual Report 2025.pdf Annual Report FY 2025	2026-04-17	English
Nykode Therapeutics - Annual Report 2025 Report Publication Announcement	2026-04-17	English
Nykode Therapeutics Highlights Robust Immunogenicity and Promising Clinical Activity for Abi-Suva at ICHNO 2026 - Attachment: 260320 - ICHNO Press Release_FINAL.pdf Regulatory Filings	2026-03-20	English
Nykode Therapeutics Highlights Robust Immunogenicity and Promising Clinical Activity for Abi-Suva at ICHNO 2026 Regulatory Filings FY 2026	2026-03-20	English
Nykode Therapeutics Announces Upcoming Presentations at AACR 2026 and NextGen Biomed 2026 - Attachment: 260318 AACR and NextGen_FINAL.pdf Regulatory Filings	2026-03-18	English
Nykode Therapeutics Announces Upcoming Presentations at AACR 2026 and NextGen Biomed 2026 Regulatory Filings	2026-03-18	English
Nykode Therapeutics to Present at DNB Carnegie Conference on March 10, 2026 - Attachment: 260309 Nykode DNB Carnegie_FINAL.pdf Regulatory Filings	2026-03-09	English
Nykode Therapeutics to Present at DNB Carnegie Conference on March 10, 2026 Regulatory Filings	2026-03-09	English
Nykode Therapeutics to Present New Data and Participate in Panel Discussion at the 9th Annual Antigen-Specific Immune Tolerance Summit (ASIT) - Attachment: 260303_ASIT press release - FINAL.pdf Regulatory Filings	2026-03-03	English
Nykode Therapeutics to Present New Data and Participate in Panel Discussion at the 9th Annual Antigen-Specific Immune Tolerance Summit (ASIT) Regulatory Filings	2026-03-03	English
Nykode Therapeutics - Quarterly Report Q4 2025 - Attachment: 260225 Nykode Q4 2025 Presentation_webcast_FINAL.pdf Investor Presentation	2026-02-25	English
Nykode Therapeutics - Quarterly Report Q4 2025 - Attachment: 260225 Nykode Quarterly Report Q4 2025.pdf Interim / Quarterly Report Q4 2025	2026-02-25	English
Nykode Therapeutics - Quarterly Report Q4 2025 Report Publication Announcement	2026-02-25	English
Nykode Therapeutics - Grant of share options - Attachment: Attachment Options 300126.pdf Director's Dealing	2026-01-30	English
Nykode Therapeutics - Grant of share options Share Issue/Capital Change	2026-01-30	English
Nykode Therapeutics ASA - Minutes of Extraordinary General Meeting - Attachment: 260121-Nykode-EGM-minutes.pdf Declaration of Voting Results & Voting Rights Announcements	2026-01-21	English
Nykode Therapeutics ASA - Minutes of Extraordinary General Meeting Declaration of Voting Results & Voting Rights Announcements	2026-01-21	English